glp-1 weight loss drugs tirzepatide semaglutide Troubling Findings in Study of Compounders Most weight loss medications work

Oral semaglutide and oral tirzepatide options may offer a more sustainable long-term approach for people who want to reduce rather than eliminate GLP-1 support

Wu RM, Chen RC, Chiueh CC (2000) Effect of MAO-B inhibitors on MPP+ toxicity in Vivo

So, Im super grateful

Phospholipid synthesis in mammalian cells, in Biochemistry of lipids, lipoproteins and membranes (Amsterdam, The Netherlands: Elsevier), 227258)

When participants who had been taking semaglutide were randomized to either continue the medication or switch to placebo after 20 weeks, those who continued treatment maintained their weight loss, while those switched to placebo regained significant weight